Navigation Links
SCOLR Pharma, Inc. Reports Third Quarter 2009 Financial Results
Date:11/6/2009

BOTHELL, Wash., Nov. 6 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (Amex: DDD) today reported financial results for the three and nine months ended September 30, 2009.

Stephen J. Turner, SCOLR Pharma's President and CEO, said, "We continue to advance discussions related to licensing our 12-hour ibuprofen formulation. Several potential partners have committed significant resources in time, personnel and external resources as they evaluate the potential commercial and/or licensing opportunity. In the nutraceutical area, we have increased our sales and marketing efforts and are optimistic we will be able to expand our existing revenue streams from extended release supplements. Royalties received from Perrigo continue to improve on a quarterly basis, and we expect to see further increases as we expand the reach of our products to new customers. In addition, we have made significant strides in support of our recent marketing efforts on new product offerings outside of the Perrigo relationship both within the US and abroad. We expect to be able to introduce newly formulated products in 2010 based on our meetings with numerous international, national and regional retailers and potential partners.

We continue to make progress in reducing our operating expenses including reductions in salary and rent expenses. We renegotiated the lease for our corporate facility to reduce the amount of leased space to 15,615 square feet from 20,468 square feet and reduce our rental payments. In addition, effective November 1, 2009, the Company will be allowed to pay up to $18,000 of its monthly rent for twelve months through draw downs on the letter of credit which secures the lease. In addition, we eliminated one executive position and reduced base salaries for two executive officers. These additional savings will provide us the opportunity to pr
'/>"/>

SOURCE SCOLR Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen
2. SCOLR Pharma, Inc. Reports Third Quarter 2008 Financial Results
3. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
4. CB1400, Patented by Canopus BioPharma, Enters Phase II Clinical Trials for the Prevention of Mucositis in Patients With Cancer of the Head and Neck
5. FluoroPharma, Inc. to Report Preclinical Data on Alzheimers Disease and Prostate Cancer PET Imaging Agents
6. DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
7. Neurobiological Technologies Partner, Celtic Pharma, Announces Results of XERECEPT(R) Phase 3 Clinical Program
8. Pangu BioPharma, aTyr Pharmas Subsidiary in Hong Kong, Files Three Patent Applications
9. Strativa Pharmaceuticals Development Partner, BioAlliance Pharma, Presents Phase III Study Results of Miconazole Lauriad(R) for the Treatment of Oropharyngeal Candidiasis
10. Northern Light Adds 4,000 Bio-Pharma, Health Sciences and General Business News and Journal Sources from EBSCO Publishing
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)...   Memorial Hermann Health System and The ... a new partnership to provide a new level of specialized ... in the greater Houston area. ... exclusive provider of professional breast radiology services for five of ... The Woodlands , Northeast, Southwest and ...
(Date:8/21/2014)... 21, 2014  eRelevance Corporation ( www.erelevancecorp.com ), ... that it has completed integration with Nextech, a ... Surgery and Dermatology practices. "Integration allows ... healthcare practices using Nextech," stated Bob Fabbio ... information from the EMR we are able to ...
(Date:8/21/2014)... 21, 2014 /CNW/ - Eisai Limited is pleased to support ... first-of-its-kind comic book available in Canada . ... specifically to educate children and their parents about epilepsy, the ... affecting more than 300,000 Canadians. Eisai is guided by a ... in which the patient is central – there was a ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4eRelevance Corporation Integrates with Nextech Electronic Medical Records 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2
... , , ROCHESTER, Minn. , Feb. 5 ... to speed the introduction of new medical treatments developed by ... plaguing the clinical trials process: the lack of a systematic, ... burdens associated with trial start-up administration. , Clinical testing of ...
... SOUTH SAN FRANCISCO, Calif. , Feb. 5 Poniard ... oncology therapies, today announced that Ronald Martell , chief executive officer, ... Investor Conference on Tuesday, February 9, 2010 at 1:00 ... York City . , A live audio webcast of the corporate overview ...
Cached Medicine Technology:Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 2Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 3Centerphase Solutions, Inc. Launches New Clinical Trials Business Model Company 4Poniard Pharmaceuticals to Present at 12th Annual BIO CEO and Investor Conference 2
(Date:8/22/2014)... The New Jersey Institute for Food, ... University of New Jersey has joined forces with ... educate young people about health and nutrition in a ... both organizations. , The partnership will encompass quarterly custom ... and video communications. ChopChop Magazine features plenty of ...
(Date:8/22/2014)... 2014 (HealthDay News) -- The U.S. Drug Enforcement Administration ... painkillers containing hydrocodone, which has been tied to a ... The new restrictions would cover prescription narcotic drugs such ... in the same regulatory class as painkillers such as ... access to a three-month supply of the drug and ...
(Date:8/22/2014)... low levels of nicotine may reduce addiction without ... new study from the University of Waterloo. ... Cancer Epidemiology monitored the smoking behaviours of ... of cigarettes with markedly reduced nicotine levels. , ... of which have very similar levels of nicotine ...
(Date:8/22/2014)... The leather seat covers provided ... experts to meet customers’specific product needs. Recently, the company has ... . , The company wants to provide worldwide clients ... the seat cover industry for a long time. According to ... offered at promotional rates. Among all the new products, ...
(Date:8/22/2014)... 2014 AcousticSheep LLC participated in one ... – the first Color Run – otherwise known as the “Happiest ... 2014 and over 10,900 participants from Erie, surrounding areas, and even ... in one of the largest running events put on in Erie, ... the “Happiest 5K on the Planet.” The event took place on ...
Breaking Medicine News(10 mins):Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 2Health News:New Jersey Institute for Food, Nutrition & Health to Launch Innovative Partnership with Award-Winning Children’s Anti-Obesity Organization, ChopChop Kids 3Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 2Health News:U.S. to Tighten Access to Certain Narcotic Painkillers 3Health News:Smokers consume same amount of cigarettes regardless of nicotine levels 2Health News:Custom 1993-1996 Chevrolet Camaro Leather Seat Covers Now for Sale at Lseat.com 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 2Health News:RunPhones® Reveals Erie, PA Enthusiasm Impressed Color Run Director 3
... , , - Ninety-minute Report ... SMILEY and NIGHTLY BUSINESS REPORT - , , ... a major address on healthcare to a joint session of Congress ... and NIGHTLY BUSINESS REPORT are collaborating to provide a timely and ...
... , , LOS ... Dr. Christina Restrepo has achieved diplomate status with the American College ... Restrepo graduated in 2003 from the University of Florida College of ... small animal medicine and surgery at the renowned Animal Medical Center ...
... , , Actuaries Urge President to ... WASHINGTON, Sept. 8 The American Academy of Actuaries ... is expecting there to be an increase in the number of people without ... According to last year,s Census Bureau estimates, nearly 46 million people were ...
... Only Hospital in Northern and Central California to ... REDWOOD CITY, Calif., Sept. 8 Sequoia Hospital announced that ... ablation procedures, making it the highest total volume A-Fib ablation ... Numerous medical journals and world-wide ablation center surveys have documented ...
... when disease will respond to cancer drug , TUESDAY, Sept. ... into whether certain aggressive cancers -- including those that attack ... certain anti-cancer drug. , The key appears to lie in ... 6 online issue of Nature Medicine . , Researchers ...
... diabetes in children, University of Iowa researchers have discovered ... and insulin secretion. The mechanism involves a protein called ... human heart arrhythmias. The findings, which ... Proceedings of the National Academy of Sciences , ...
Cached Medicine News:Health News:PBS Special on Health Care Reform 2Health News:PBS Special on Health Care Reform 3Health News:PBS Special on Health Care Reform 4Health News:Animal Dermatology Clinic Marina del Rey Announces Dr. Christina Restrepo, DVM Achieves Diplomate Status With the American College of Veterinary Dermatology 2Health News:Actuaries: Unemployment May Boost Number of Uninsured 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 2Health News:Sequoia Hospital Announces High Volume Cardiac Arrhythmia Program 3Health News:Team reveals molecular mechanism underlying a form of diabetes 2
... II Left Ventricular Assist System (LVAS) is ... to restore hemodynamic function and improve patient ... rotary action of a single-moving part, the ... circulatory support by pumping blood from the ...
... adjustable wheelchair scale accommodates standard to extra-wide ... anti-tip devices. The low-profile, heavy-duty, anodized aluminum ... than 1/2" high providing easy access for ... wall-mounted, stainless steel digital readout. The 6772 ...
... Bariatric Stand-On Scale is designed to accommodate ... physicians scales only weigh up to 300 ... surface, or patients position on the scale., ... profile only 1 1/4 inches high. ...
... is synthesized by the parathyroid glands ... decreased extracellular calcium concentrations. PTH prevents ... decreasing calcium excretion by the kidney. ... PTH is rapidly degraded into 4 ...
Medicine Products: